- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01219595
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
January 28, 2016 updated by: University of Wisconsin, Madison
The purpose of the research is to determine if eating sweetened, dried cranberries or strawberry fruit pieces will increase the types of different E. coli bacteria in the intestines which may reduce the likelihood of a major, or highly harmful urinary type of bacteria which cause urinary tract infections in susceptible women.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a research study about the number and types of bacteria that cause urinary tract infections (E. coli strains) that are present in the intestine.
The bacteria will be collected and analyzed before and after eating either sweetened, dried cranberries or strawberry fruit pieces.
This study will help us learn more about whether or not the components of consumed sweetened, dried cranberries or strawberry fruit pieces reduce the numbers of harmful E. coli bacteria in the vaginal and intestinal tracts, thereby reducing the number of urinary tract infections among women.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin-Madison
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women, ages 18-65
- History of recurrent urinary tract infections defined as three in the past year, or two in the last six months
- Subjects must be willing to follow the study protocol that includes consuming the mandatory daily dose of cranberries or strawberry fruit pieces and traveling to the UWHC Urology clinic for scheduled rectal and vaginal swab procedures.
The non-UTI-susceptible group will include women ages 18-65 with no history of recurrent UTI's as defined above.
Exclusion Criteria:
Women who:
- Are pregnant
- Have an immune compromising disease
- Have diabetes
- Have kidney stones
- Have chronic bowel inflammatory disease
- Have known allergies to cranberries, strawberries, elderberries, or wheat fiber
Non-UTI-susceptible group will include women ages 18-65 with no history of recurrent UTI's as defined above.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Part 1
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for two weeks.
|
Women in Arm 1 will consume one serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for two weeks.
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for three separate, two-week periods.
Each two week period will be separated by a two-week interval.
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for one 4-week period.
|
Other: No treatment
20 non-UTI susceptible women will be enrolled to collect data on the types of E. coli flora present in non-UTI women.
|
Subjects in the non-UTI susceptible group will have one visit where one vaginal and one rectal swab will be collected.
|
Active Comparator: Part 2A
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for three separate, two-week periods.
Each two week period will be separated by a two-week interval.
|
Women in Arm 1 will consume one serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for two weeks.
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for three separate, two-week periods.
Each two week period will be separated by a two-week interval.
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for one 4-week period.
|
Placebo Comparator: Part 2B
1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for three separate, two-week periods.
Each two week period will be separated by a two-week interval.
|
1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for three separate, two-week periods.
Each two week period will be separated by a two-week interval.
1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for one 4-week period.
|
Active Comparator: Part 3A
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for one 4-week period.
|
Women in Arm 1 will consume one serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for two weeks.
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for three separate, two-week periods.
Each two week period will be separated by a two-week interval.
1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for one 4-week period.
|
Placebo Comparator: Part 3B
1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for one 4-week period.
|
1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for three separate, two-week periods.
Each two week period will be separated by a two-week interval.
1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for one 4-week period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pre-treatment heterogeneity or prevalence
Time Frame: Day 1 - prior to start of study treatment
|
1) Prevalence or heterogeneity of E. coli strains in UTI susceptible women pre-treatment
|
Day 1 - prior to start of study treatment
|
Post-treatment heterogeneity
Time Frame: 2 weeks, 1 month, or 3 months
|
2) a change in the heterogeneity of strains post treatment
|
2 weeks, 1 month, or 3 months
|
Patient acceptance of study regimen
Time Frame: 2 weeks, 1 month, or 3 months
|
3) patient acceptance of the study regimen
|
2 weeks, 1 month, or 3 months
|
Maintenance of heterogeneity in the intestinal flora
Time Frame: Approximately 3 months
|
To determine whether a shift towards strain heterogeneity in the intestinal flora can be maintained over a three month period.
|
Approximately 3 months
|
Measure Effects of sweetened, dried cranberries on E. coli clonotypes over three two-week exposures
Time Frame: Approximately 3 months
|
Measure effects of sweetened, dried cranberries on E. coli clonotypes over three two-week exposures
|
Approximately 3 months
|
Measure effects of sweetened, dried cranberries on E. coli clonotypes over one 4-week exposure
Time Frame: 2 weeks, 1 month, or 3 months
|
Measure effects of sweetened, dried cranberries on E. coli clonotypes over one 4-week exposure
|
2 weeks, 1 month, or 3 months
|
Measure the UTI recurrence
Time Frame: 2 weeks, 1 month, or 3 months
|
Measure the UTI recurrence after 6 months from the beginning of the study.
|
2 weeks, 1 month, or 3 months
|
Comparison of sweetened dried cranberries to a placebo group
Time Frame: 2 weeks, 1 month, or 3 months
|
Comparison of sweetened dried cranberries to a placebo group (strawberry fruit pieces)
|
2 weeks, 1 month, or 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Walter Hopkins, PhD, University of Wisconsin, Madison
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
September 1, 2012
Study Completion (Actual)
September 1, 2012
Study Registration Dates
First Submitted
October 8, 2010
First Submitted That Met QC Criteria
October 8, 2010
First Posted (Estimate)
October 13, 2010
Study Record Updates
Last Update Posted (Estimate)
January 29, 2016
Last Update Submitted That Met QC Criteria
January 28, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2010-0107
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Tract Infection
-
Gloucestershire Hospitals NHS Foundation TrustUnknownCatheter Infection | Urinary Tract Infection in Pregnancy | Urinary Tract Infection Following Delivery
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedUrinary Tract Infection | Recurrent Urinary Tract InfectionCanada
-
National Institute of Allergy and Infectious Diseases...TerminatedUrinary Tract InfectionUnited States
-
University Of PerugiaUnknownUrinary Tract Infection
-
NanovibronixShaare Zedek Medical CenterUnknownUrinary Tract InfectionIsrael
-
Hadassah Medical OrganizationUnknown
-
National Center for Complementary and Integrative...Office of Dietary Supplements (ODS)UnknownUrinary Tract InfectionCanada
-
Impatients N.V. trading as myTomorrowsInmunotek S.L.No longer availableUrinary Tract Infections | Bladder Infection | Recurrent Urinary Tract Infection | Urinary Tract Infection Bacterial | Chronic Urinary Tract InfectionCzechia, Denmark, Serbia, France, Germany, Turkey, Belgium, Finland, Luxembourg, Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden
-
Hospital de Clinicas de Porto AlegreUnknownUrinary Tract Infection | Respiratory Tract InfectionBrazil
-
Bactiguard ABRehab Station StockholmCompletedComplications; Catheter, Urinary Infection or InflammationSweden
Clinical Trials on Sweetened, dried cranberries
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); University of WashingtonCompletedObesity | Cardiovascular Disease | Type 2 Diabetes Mellitus | Intestinal Permeability | Low-grade Chronic InflammationUnited States
-
University of California, DavisRecruiting
-
Harvard School of Public Health (HSPH)CompletedBiomarkersUnited States
-
Instituto de Nutrición y Tecnología de los AlimentosUnknown
-
Hadassah Medical OrganizationUnknownPremature Birth | Fetal Membranes, Premature RuptureIsrael
-
University of Missouri-ColumbiaCompletedInsulin Sensitivity | Insulin ToleranceUnited States
-
University of OklahomaNational Institute on Drug Abuse (NIDA); American University of Beirut Medical... and other collaboratorsCompletedWaterpipe Smoking | Smoking, HookahUnited States
-
Monica Flores-MuñozInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Universidad...Completed
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedCardiovascular Diseases | Hypertension | Healthy | Obesity | Diabetes | Overweight | Metabolic Syndrome | PreDiabetes | Overweight and Obesity | Cardiovascular Risk Factor | DysglycemiaCanada
-
Aarhus University HospitalLG Life SciencesCompleted